Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Gains from Investment Securities (2016 - 2026)

Rockwell Medical filings provide 15 years of Gains from Investment Securities readings, the most recent being $981000.0 for Q4 2025.

  • On a quarterly basis, Gains from Investment Securities fell 38.53% to $981000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $1.4 million, a 58.54% decrease, with the full-year FY2025 number at $1.0 million, down 50.3% from a year prior.
  • Gains from Investment Securities hit $981000.0 in Q4 2025 for Rockwell Medical, up from $124000.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $1.6 million in Q4 2024 to a low of -$149000.0 in Q2 2023.
  • Median Gains from Investment Securities over the past 5 years was $146000.0 (2025), compared with a mean of $394666.7.
  • Biggest five-year swings in Gains from Investment Securities: soared 1071.88% in 2024 and later plummeted 90.27% in 2025.
  • Rockwell Medical's Gains from Investment Securities stood at $150000.0 in 2021, then surged by 221.33% to $482000.0 in 2022, then increased by 26.97% to $612000.0 in 2023, then skyrocketed by 160.78% to $1.6 million in 2024, then plummeted by 38.53% to $981000.0 in 2025.
  • The last three reported values for Gains from Investment Securities were $981000.0 (Q4 2025), $124000.0 (Q3 2025), and $148000.0 (Q2 2025) per Business Quant data.